PP_1170x120_10-25-21

three-dimensional printing

Spritam is first FDA-approved 3D printed drug

Spritam is first FDA-approved 3D printed drug

BLUE ASH, Ohio — Aprecia Pharmaceuticals Co. has received Food and Drug Administration approval for Spritam levetiracetam for oral use, an epilepsy treatment made using three-dimensional printing (3DP) technology. The company said Monday that the medication is the first drug product manufactured with 3DP technology that has been approved by the FDA. Spritam uses Aprecia’s

Adheris Health